4Lozano J V,Pallares V, Cea-CalvoL, et al. Serum lipid Profiles and their relationship to cardiovascular disease in the elderly: the PREV ICTUS study[J]. Curr reed Res Opin, 2008,24:659- 670.
5Nair A P,Dartow B. Lipid managemenl in the geriatric patient[J].Endocrinol Metab clin North AM, 2009,38 : 185- 206.
6ESC/EAS Guidelines for the anagement of dyslipidaemias[J]. European Heart Joumal,2011,32:1769-1818.
7Lewis S J,Moye L A, Sacks F M,et al. Effect of pravastatin on cardiovascular events in older patients with myocardial infarction and cholesterol levels in the average range Results of the Cholesterol and Recurrent Events (CARE) trial[J]. Ann Intern Mad, 1998, 129 :68-689.
8Afilalo J, Duqre G, Steele R, et al. Statins for Secondary prevention in elderly patients: a hierarchical bayesianmetaanalysis[J]. J Am Coll Cardiol, 2008,51,37-45.
9Downs J R, Clearfield M, Weis S, et al. Primary Prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/Tex CAPS. Air Force/ Texas Coronary Atherosclerosis Prevention study [J]. JAMA, 1998,279 : 1615- 1622.
10Jim Glare. Meta-andysis: Statins for primary prevention of cardio vascular disease in those with risk factors[J]. BMJ, 2009,338: b2376.
